Public, Industry Agree on Biotech

The most important message for biotechnology in the new Office of Technology Assessment's study of public perceptions of the biotechnology industry is that knowledge dispels concern. Based on a nationwide probability sampling conducted last fall by Lou Harris & Associates, the study finds that nearly half of American adults describe themselves as very interested, concerned and/or knowledgeable about science and technology. It also reveals that fully 80 per cent of the American public expects tha

Written byRichard Godown
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

What is the object lesson here? That our chief critic is a dog who has seen his day? That an enlightened electorate has somehow been won over? That despite constant efforts by some to create fear and spread doubt, the potential benefits of biotechnology in health care, agriculture and the environment are widely perceived by a clear-eyed public? Well, not quite.

What does come through is that a properly informed public is most likely to accept some risk. When it is explained that genetically engineered organisms can significantly increase farm production, a majority would be in favor of their use, even when there is a one-in-a-thousand chance of losing some lo cal species of plant or fish. But, the same is not true if the risk is unquantified.

Right now, figures indicate that the vast majority of the public would favor small-scale environmental application of genetically engineered organisms, but less ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Accelerating Recombinase Reprogramming with Machine Learning

Accelerating Recombinase Reprogramming with Machine Learning

Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo

Products

waters-logo

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

zymo-research-logo

Zymo Research Partners with Harvard University to Bring the BioFestival to Cambridge, Empowering World-class Research

10x-genomics-logo

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA